Finally, we confirmed the in vivo GBM and GBMO mRNA findings, at the protein level by performing an analysis on the expression of IFN-γ receptors and STAT1 in SATB2+ and HOPX+ cells in our GBMO. The gene discussed is STAT1; the disease is glioblastoma.